Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Sep 1:14:1195181.
doi: 10.3389/fendo.2023.1195181. eCollection 2023.

Effect of tamoxifen in patients with thin endometrium who underwent frozen-thawed embryo transfer cycles: a retrospective study

Mengxia Ji  1 , Xiaohua Fu  1 , Danni Huang  2 , Ruifang Wu  1 , Yunqing Jiang  1 , Qiongxiao Huang  1
Affiliations

Effect of tamoxifen in patients with thin endometrium who underwent frozen-thawed embryo transfer cycles: a retrospective study

Mengxia Ji et al. Front Endocrinol (Lausanne). .

Abstract

Introduction: Thin endometrium leads to an impaired implantation rate. The aim of the study is to compare the clinical outcomes of tamoxifen (TAM) and hormone replacement therapy (HRT) used in patients with thin endometrium (<7mm) in frozen-thawed embryo transfer (FET)cycles.

Methods: A total of 176 FET cycles with thin endometrium were retrospectively analyzed in our center from Jan 2020 to May 2022. According to patients' own will, 112 patients were allocated to the HRT group and 64 patients chose the TAM protocol. Clinical outcomes were compared between two groups.

Result: The duration of treatment was shorter in the TAM group(12.03±2.34d) than the HRT group (16.07±2.52 d), which was statistically different (p<0.05). The endometrial thickness on the transfer day of the TAM group (7.32±1.28 mm) was significantly thicker than that of the HRT group (6.85±0.89mm, p<0.05). The clinical pregnancy rate of the TAM group (50.0%) was higher than that of the HRT group (36.6%), but there was no significant difference (p >0.05). The early miscarriage rate was significantly lower in the TAM group compared with the HRT group (5.9% Vs 26.8%, adjusted OR 0.10, p<0.05), while the live birth rate was higher in the TAM group (46.9% Vs 26.8%, adjusted OR 2.24, p<0.05) compared with the HRT group.

Conclusion: For patients with thin endometrium, TAM effectively improved the endometrial thickness and increased the live birth rate. TAM can be used as an alternative protocol for patients with thin endometrium.

Keywords: frozen embryo transfer (FET); hormone replacement therapy (HRT); in vitro fertilization; tamoxifen; thin endometrium (TE).

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References

    1. Richter KS, Bugge KR, Bromer JG, Levy MJ. Relationship between endometrial thickness and embryo implantation, based on 1,294 cycles of in vitro fertilization with transfer of two blastocyst-stage embryos. Fertil steril (2007) 87(1):53–9. doi: 10.1016/j.fertnstert.2006.05.064 - DOI - PubMed
    1. Chen SL WF, Luo C, Chen X, Shi XY, Zheng HY, Ni PY. Combined analysis of endometrial thickness and pattern in predicting outcome of in vitro fertilization and embryo transfer a retrospective cohort study. Reprod Biol Endocrinol (2010) 8(8):30–0. doi: 10.1186/1477-7827-8-30 - DOI - PMC - PubMed
    1. Wu Y, Gao X, Lu X, Xi J, Jiang S, Sun Y, et al. Endometrial thickness affects the outcome of in vitro fertilization and embryo transfer in normal responders after GnRH antagonist administration. Reprod Biol Endocrinol (2014) 12:96. doi: 10.1186/1477-7827-12-96 - DOI - PMC - PubMed
    1. Mahajan N, Sharma S. The endometrium in assisted reproductive technology: How thin is thin? J Hum Reprod Sci (2016) 9(1):3–8. doi: 10.4103/0974-1208.178632 - DOI - PMC - PubMed
    1. Liu KE, Hartman M, Hartman A. Management of thin endometrium in assisted reproduction: a clinical practice guideline from the Canadian Fertility and Andrology Society. Reprod BioMed Online (2019) 39(1):49–62. doi: 10.1016/j.rbmo.2019.02.013 - DOI - PubMed

Publication types